Home

Vivo Ventures V, LLC

CIK 1399028 · last filed 2019-11-25

Vivo Ventures V, LLC is a corporate insider who has filed 18 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing shows the insider sold $287.2K of SLNO on Nov 25, 2019. Across all open-market trades the lifetime net is −$30.9M, making them a net seller over the disclosed history. The firm reports its address in Palo Alto, CA. 29 SEC filings were submitted jointly with Vivo Ventures Fund V, L.P.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

7

Total Filings

18

Lifetime Open-Market Net

-$30.90M

Filer Profile

Reported Address
505 HAMILTON AVENUE, SUITE 200
PALO ALTO, CA 94301
Phone
(650) 688-0818
State of Incorporation
DE
Related Filers
Vivo Ventures Fund V, L.P. — 29 joint filings, latest 2019-12-03
Vivo Ventures V Affiliates Fund, L.P. — 29 joint filings, latest 2019-12-03
BIOASIA MANGEMENT LLC — 2 joint filings, latest 2014-11-20
BIOTECHNOLOGY DEVELOPMENT FUND II LP — 2 joint filings, latest 2014-11-20
Biotechnology Development Fund IV Affiliates LP — 2 joint filings, latest 2014-11-20
Frank Kung — 2 joint filings, latest 2014-11-20
VIVO VENTURES VII, LLC — same reported address
Vivo Capital Fund VIII, L.P. — same reported address
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SOLENO THERAPEUTICS INC (SLNO) Delisted 10%+ Owner 245,727 $53.01 $13.03M -$931.9K 3 2019-11-25
SOLENO THERAPEUTICS INC (SLNOW) Delisted 10%+ Owner 4,219,504 — — $6.00M 4 2018-08-09
SOLENO THERAPEUTICS INC (CAPNW) Delisted 10%+ Owner 179,260 — — $0 1 2017-04-14
Sagent Pharmaceuticals, Inc. (SGNT) Delisted 10%+ Owner 2,978,803 — — -$34.44M 2 2016-04-25
SOLENO THERAPEUTICS INC (CAPN.W) Delisted 10%+ Owner 6,922,123 — — $0 1 2016-02-09
Lite Strategy, Inc. (MEIP) Delisted 10%+ Owner 9,645 $3.20 $30.9K -$1.53M 5 2015-11-09
ALBIREO PHARMA, INC. (BIOD) Delisted 10%+ Owner 56,188 — — $0 1 2007-05-18

Recent Filings

18 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2019-11-25 SOLENO THERAPEUTICS INC (SLNO) Delisted Sell (S) −185,013 -$287.2K EDGAR
2019-11-20 SOLENO THERAPEUTICS INC (SLNO) Delisted Sell (S) −124,887 -$193.6K EDGAR
2019-11-15 SOLENO THERAPEUTICS INC (SLNO) Delisted Sell (S) −291,072 -$451.2K EDGAR
2018-08-09 SOLENO THERAPEUTICS INC (SLNOW) Delisted Other (J) +978,447 $3.33M EDGAR
2017-12-19 SOLENO THERAPEUTICS INC (SLNOW) Delisted Buy (P) +3,256,440 $6.00M EDGAR
2017-10-04 SOLENO THERAPEUTICS INC (SLNOW) Delisted Grant (A) +16,827 $8.8K EDGAR
2017-07-17 SOLENO THERAPEUTICS INC (SLNOW) Delisted Grant (A) +14,344 $8.7K EDGAR
2017-04-14 SOLENO THERAPEUTICS INC (CAPNW) Delisted Grant (A) +13,888 $8.7K EDGAR
2016-09-01 — U −9,041,292 -$196.65M
2016-04-25 Sagent Pharmaceuticals, Inc. (SGNT) Delisted Sell (S) −6,015 -$81.5K EDGAR
Showing 1–10 of 18
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.